The iQ Group Global secures worldwide license for Harvard
Affordable rapid multiplexed biomarker detection at the point-of-care for patients and practitioners...
Stay updated with breaking news from Technology Access Framework. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Affordable rapid multiplexed biomarker detection at the point-of-care for patients and practitioners...
The low-cost multiplexed electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics to be put into the hands of...
Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Australian biotech company The iQ Group Global Ltd. announced that the Institute's electrochemical eRapid technology has been licensed to Antisoma Therapeutics Pty. Ltd., a subsidiary of The iQ Group Global.
IQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
Wyss Institute for Biologically Inspired Engineering at Harvard University, March 07, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Australian